David D. Hebrink

608 total citations
16 papers, 495 citations indexed

About

David D. Hebrink is a scholar working on Immunology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, David D. Hebrink has authored 16 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 6 papers in Pathology and Forensic Medicine and 5 papers in Molecular Biology. Recurrent topics in David D. Hebrink's work include Multiple Sclerosis Research Studies (5 papers), Immunotherapy and Immune Responses (4 papers) and T-cell and B-cell Immunology (4 papers). David D. Hebrink is often cited by papers focused on Multiple Sclerosis Research Studies (5 papers), Immunotherapy and Immune Responses (4 papers) and T-cell and B-cell Immunology (4 papers). David D. Hebrink collaborates with scholars based in United States, United Kingdom and Austria. David D. Hebrink's co-authors include Brian G. Weinshenker, Elizabeth J. Atkinson, Orhun H. Kantarci, Cynthia T. McMurray, Mariza de Andrade, Sara J. Achenbach, Janet Schaefer-Klein, Marcelo Matiello, Guy J. Buckle and Alicja Waliszewska and has published in prestigious journals such as Neurology, Mayo Clinic Proceedings and Journal of Neuroimmunology.

In The Last Decade

David D. Hebrink

16 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David D. Hebrink United States 13 264 207 144 103 76 16 495
Gianna Costa Italy 13 159 0.6× 219 1.1× 168 1.2× 69 0.7× 43 0.6× 24 505
Ilse A Hoppenbrouwers Netherlands 9 167 0.6× 228 1.1× 106 0.7× 71 0.7× 55 0.7× 10 419
Raffaele Murru Italy 11 125 0.5× 183 0.9× 83 0.6× 77 0.7× 61 0.8× 23 368
М. А. Судомоина Russia 13 152 0.6× 127 0.6× 173 1.2× 50 0.5× 74 1.0× 24 431
Magdalena Lindén Sweden 10 173 0.7× 152 0.7× 49 0.3× 56 0.5× 59 0.8× 11 352
Bárbara Alonso Spain 14 262 1.0× 109 0.5× 109 0.8× 45 0.4× 93 1.2× 22 527
Chang-Sung Koh Japan 11 218 0.8× 133 0.6× 90 0.6× 57 0.6× 75 1.0× 19 428
Marte W. Gustavsen Norway 11 111 0.4× 169 0.8× 101 0.7× 44 0.4× 28 0.4× 12 348
Ben J. E. Raveney Japan 12 420 1.6× 78 0.4× 184 1.3× 93 0.9× 90 1.2× 21 711
Sunny Malhotra Spain 12 211 0.8× 108 0.5× 257 1.8× 38 0.4× 71 0.9× 26 484

Countries citing papers authored by David D. Hebrink

Since Specialization
Citations

This map shows the geographic impact of David D. Hebrink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David D. Hebrink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David D. Hebrink more than expected).

Fields of papers citing papers by David D. Hebrink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David D. Hebrink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David D. Hebrink. The network helps show where David D. Hebrink may publish in the future.

Co-authorship network of co-authors of David D. Hebrink

This figure shows the co-authorship network connecting the top 25 collaborators of David D. Hebrink. A scholar is included among the top collaborators of David D. Hebrink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David D. Hebrink. David D. Hebrink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Matiello, Marcelo, Janet Schaefer-Klein, David D. Hebrink, et al.. (2011). Genetic analysis of aquaporin-4 in neuromyelitis optica. Neurology. 77(12). 1149–1155. 40 indexed citations
2.
Kantarci, Orhun H., David D. Hebrink, Janet Schaefer-Klein, et al.. (2008). Interferon Gamma Allelic Variants. Archives of Neurology. 65(3). 349–57. 30 indexed citations
3.
Kantarci, Orhun H., Yazmín Morales, David D. Hebrink, et al.. (2005). CCR5Δ32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis. Journal of Neuroimmunology. 169(1-2). 137–143. 30 indexed citations
4.
Kantarci, Orhun H., An Goris, David D. Hebrink, et al.. (2005). IFNG polymorphisms are associated with gender differences in susceptibility to multiple sclerosis. Genes and Immunity. 6(2). 153–161. 46 indexed citations
5.
Kantarci, Orhun H., David D. Hebrink, Sara J. Achenbach, et al.. (2004). Association of APOE polymorphisms with disease severity in MS is limited to women. Neurology. 62(5). 811–814. 62 indexed citations
6.
Kantarci, Orhun H., David D. Hebrink, Sara J. Achenbach, et al.. (2003). CTLA4 is associated with susceptibility to multiple sclerosis. Journal of Neuroimmunology. 134(1-2). 133–141. 70 indexed citations
7.
Kantarci, Orhun H., David D. Hebrink, Sara J. Achenbach, et al.. (2003). CD95 polymorphisms are associated with susceptibility to MS in women. Journal of Neuroimmunology. 146(1-2). 162–170. 27 indexed citations
8.
Kantarci, Orhun H., Timothy G. Lesnick, Ping Yang, et al.. (2002). Myeloperoxidase -463 (G®A) Polymorphism Associated With Lower Risk of Lung Cancer. Mayo Clinic Proceedings. 77(1). 17–22. 36 indexed citations
9.
Weinshenker, Brian G., David D. Hebrink, Orhun H. Kantarci, et al.. (2001). Genetic variation in the transforming growth factor β1 gene in multiple sclerosis. Journal of Neuroimmunology. 120(1-2). 138–145. 16 indexed citations
10.
Weinshenker, Brian G., David D. Hebrink, Elizabeth J. Atkinson, & Orhun H. Kantarci. (2001). Association of a tumor necrosis factor α polymorphism with MS susceptibility. Neurology. 57(7). 1341–1342. 9 indexed citations
11.
Kantarci, Orhun H., Elizabeth J. Atkinson, David D. Hebrink, Cynthia T. McMurray, & Brian G. Weinshenker. (2000). Association of a myeloperoxidase promoter polymorphism with multiple sclerosis. Journal of Neuroimmunology. 105(2). 189–194. 29 indexed citations
12.
Kantarci, Orhun H., Elizabeth J. Atkinson, David D. Hebrink, Cynthia T. McMurray, & Brian G. Weinshenker. (2000). Association of two variants in IL-1β and IL-1 receptor antagonist genes with multiple sclerosis. Journal of Neuroimmunology. 106(1-2). 220–227. 54 indexed citations
13.
Weinshenker, Brian G., David D. Hebrink, Christopher J. Klein, et al.. (2000). Genetic variation in the B7-1 gene in patients with multiple sclerosis. Journal of Neuroimmunology. 105(2). 184–188. 7 indexed citations
14.
Weinshenker, Brian G., David D. Hebrink, Dean M. Wingerchuk, et al.. (1999). Genetic variants in the tumor necrosis factor receptor 1 gene in patients with MS. Neurology. 52(7). 1500–1500. 15 indexed citations
15.
Weinshenker, Brian G., David D. Hebrink, A. Marquis Gacy, & Cynthia T. McMurray. (1998). DNA Compression Caused by an Upstream Point Mutation. BioTechniques. 25(1). 68–72. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026